发明名称 SGLT inhibitors
摘要 The present invention relates to novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of Formula I and methods of treating or preventing one or more conditions or diseases that may be regulated or normalized via inhibition of Sodium Glucose Cotransporter-2 (SGLT-2).;
申请公布号 US9018249(B2) 申请公布日期 2015.04.28
申请号 US201214344628 申请日期 2012.09.12
申请人 Panacea Biotec Limited 发明人 Jain Rajesh;Trehan Sanjay;Das Jagattaran;Nanda Gurmeet Kaur;Thungathurthi Sastry V. R. S.;Singh Nishan;Sharma Sudhir Kumar
分类号 A61K31/352;C07D311/00;C07D309/10;C07D493/08 主分类号 A61K31/352
代理机构 Lowe Hauptman & Ham, LLP 代理人 Lowe Hauptman & Ham, LLP
主权项 1. A compound of Formula I,wherein: ‘—’ is either a single bond or absent; ring A represents monocyclic or polycyclic C3-20 cycloalkyl, C6-10 aryl, 5-10 membered heteroaryl or 3-14 membered heterocyclyl ring; ring B represents monocyclic or polycyclic C3-20 cycloalkyl, C6-10 aryl, 5-10 membered heteroaryl or 3-14 membered heterocyclyl ring; U, V and W are independently selected from —H, C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, —OH, —CN, —N3, —NO2, —OCONH2, —F, —Cl, —Br, —I, —COOH, —CONH2, —CONHNH2, —NH2, —NHCONH2, —NHCSNH2, —NH(C═NH)NH2, —NHNH2, —NHCHO, —NHCOOH, —SH, —SO3H, —CH(═NOH), —CORa, —OR9, —COORa, —CONRaRb, —NRaRb, —NRaSO2Rb, —NRaCONRbRc, —NRaCORb, —NRaCOORb, —OCORa, —OCOORa, —OCONRaRb, —SRa, —S(O)Ra, —S(O)2Ra, —SO2NRaRb, —CRa (═NORb), —NHP(O) RaRb; wherein the said C1-12 alkyl, C2-12 alkenyl and C2-12 alkynyl, may be substituted with substituents selected from R11; provided that atleast two out of U, V and W represent —OR9; Z represents —(CH2)nORa, —ORa, —OCORa, —OCOORa, —OCONRaRb, C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, —CN, —OCONH2, —CHO, —COOH, —CONH2, —CONHNH2, —NH2, —NHCOOH, —CH2OH, —OH, —SH, —SO3H, —CH(═NOH), —CH(═NCN), —CORa, —COORa, —CONRaRb, —NRaRb, —NRaSO2Rb, —NRaCONRbRc, —NRaNRbRc, —NRaCORb, —NRaCOORb, —SRa, —S(O)Ra, —S(O)2Ra, —SO2NRaRb or —CRa (═NORb); wherein the said C1-12 alkyl, C2-12 alkenyl and C2-12 alkynyl, may be substituted with substituents selected from R11; R1, R2, R3 and R4 are independently selected from —H, C1-12 alkyl , C2-12 alkenyl, C2-12 alkynyl, C6-10 aryl, C3-20 cycloalkyl, 3-14 membered heterocyclyl, 5-10 membered heteroaryl, —CN, —COCN, —N3, —NO2, —OCONH2, —F, —Cl, —Br, —I, —CHO, —COOH, —CONH2, —NH2, —NHCONH2, —NHCHO, —NHCOOH, —OH, —ORa, —SH, —SO3H; wherein the said C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C6-10 aryl, C3-20 cycloalkyl, 3-14 membered heterocyclyl and 5-10 membered heteroaryl, may be substituted with substituents selected from R11; R5 represents —H, C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C6-10 aryl, C3-20 cycloalkyl, 3-14 membered heterocyclyl or 5-10 membered heteroaryl; wherein the said C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C6-10 aryl, C3-20 cycloalkyl, 3-14 membered heterocyclyl and 5-10 membered heteroaryl, may be substituted with substituents selected from R11; R6 represents —H, C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C6-10 aryl, C3-20 cycloalkyl, 3-14 membered heterocyclyl, 5-10 membered heteroaryl, —CN, —NH2, —NHCONH2, —NHCHO, —OH, —SH, —NRaRb, —NRaCONRbRc, —NRaCORb, —ORa or —SRa; wherein the said C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C6-10 aryl, C3-20 cycloalkyl, 3-14 membered heterocyclyl and 5-10 membered heteroaryl, may be substituted with substituents selected from R11; E represents O, S, SO, SO2, NR10 or a single bond; G represents C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C6-10 aryl, C3-20 cycloalkyl, 3-14 membered heterocyclyl or 5-10 membered heteroaryl; each of which may be substituted with substituents selected from C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C6-10 aryl, C3-20 cycloalkyl, 3-14 membered heterocyclyl, 5-10 membered heteroaryl, —CN, —COCN, —N3, —NO2, —OCN, —NCO, —SCN, —NCS, —OCONH2, —ONO2, —F, —Cl, —Br, —I, —CO—, —CS—, —CHO, —CHS, —COOH, —COSH, —CONH2, —CONHNH2, —CSNHNH2, —CSNH2, —NH2, —NHCONH2, —NHCSNH2, —NH(C═NH)NH2, —NHNH2, —NHCHO, —NHCHS, —NHCOOH, —NHCSOH, —OH, —SH, —SO3H, —CH(═NOH), —CH(═NCN), —CORa, —CSRa, —COORa, —CSORa, —COSRa, —CONRaRb, —CSNRaRb, —COCORa, —CONRaNRbRc, —CSNRaNRbRc, —CSNRaRb, —NRaRb, —NRaSO2Rb, —NRaCONRbRc, —NRaCSNRbRc, —NRa(C═NRb)NRcRd, —NRaNRbRc, —NRaCORb, —NRaCSRb, —NRaCOORb, —NRaCSORb, —ORa, —OCORa, —OCOORa, —OCONRaRb, —OCSRa, —OCSORa, —ONO2, —OCSNRaRb, —SRa, —S(O)Ra, —S(O)2Ra, —SO2NRaRb, —CRa(═NORb), —CRa (═NCOORb), —CRa(═NSORb), —CRa(═NSO2Rb), —C(═NRa)—NRbRc, —C(═NORa)—NRbRc, —CRa(═NCN), —NCRa, —P(O)RaRb, —P(O)ORaORb, —P(O)RaORb, —P(O)NRaORb, —P(O)NRaRb, —OP(O)RaRb, —NHP(O)RaRb; wherein the said C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C6-10 aryl, C3-20 cycloalkyl, 3-14 membered heterocyclyl and 5-10 membered heteroaryl, may be substituted with substituents selected from C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C6-10 aryl, C3-20 cycloalkyl, 3-14 membered heterocyclyl, 5-10 membered heteroaryl, —CN, —COCN, —N3, —NO2, —OCN, —NCO, —SCN, —NCS, —OCONH2, —ONO2, —F, —Cl, —Br, —I, —CO—, —CS—, —CHO, —CHS, —COOH, —COSH, —CONH2, —CONHNH2, —CSNHNH2, —CSNH2, —NH2, —NHCONH2, —NHCSNH2, —NH(C═NH)NH2, —NHNH2, —NHCHO, —NHCHS, —NHCOOH, —NHCSOH, —OH, —SH, —SO3H, —CH(═NOH), —CH(═NCN); When E is a single bond or Nitrogen, then E and R6 can be joined together to farm a saturated or unsaturated C3-10 cycloalkyl or 3-10 membered heterocyclyl ring, which may further be fused to one or more C3-10 cycloalkyl, 3-10 membered heterocyclyl, C5-10 aryl or 5-10 membered heteroaryl ring. The ring thus formed may further be substituted with substituents selected from R12; G and R6 can be joined together to form a saturated or unsaturated C3-10 cycloalkyl or 3-10 membered heterocyclyl ring, which may further be fused to one or more C3-10 cycloalkyl, 3-10 membered heterocyclyl, C5-10 aryl or 5-10 membered heteroaryl ring. The ring thus formed may further be substituted with substituents selected from R12; R7 represents —H, —OH or —OR9; R8 represents —H, —CHO, —COOH, —CONH2, —OH, —CH(═NOH), —CORa, —COORa, —CONRaRb, —CRa (═NORb), —ORa, or —(CH2)nORa; or R7 and R8 can be joined together to form a saturated or unsaturated ring, in which one or more methylene groups or methyne groups can be replaced with O, S, NRa or oxo; the ring thus formed may be substituted with substituents selected from R12; or R8 and Z can be joined together to form a saturated or unsaturated ring, in which one or more methylene groups or methyne groups can be replaced with O, S, NRa or oxo; the ring thus formed may be substituted with substituents selected from R12; R9 represents —H, C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C6-10 aryl, C3-20 cycloalkyl, 3-14 membered heterocyclyl, 5-10 membered heteroaryl, —CHO, —CONH2, —CORa, —CONRaRb, —S(O)2Ra, —SO2NRaRb, —P(O)RaRb, —P(O)ORaORb, —P(O)RaORb, —P(O)NRaORb or —P(O)NRaRb; wherein the said C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C6-10 aryl, C3-20 cycloalkyl, 3-14 membered heterocyclyl and 5-10 membered heteroaryl, may be substituted with substituents selected from C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C6-10 aryl, C3-20 cycloalkyl, 3-14 membered heterocyclyl, 5-10 membered heteroaryl, —CHO, —CONH2, —CORa, —CONRaRb, —S(O)2Ra, —SO2NRaRb, —P(O)RaRb, —P(O)ORaORb, —P(O)RaORb, —P(O)NRaORb, —P(O)NRaRb; further wherein the said C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C6-10 aryl, C3-20 cycloalkyl, 3-14 membered heterocyclyl and 5-10 membered heteroaryl, may be substituted with substituents selected from R13; R10 represents —H, C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C6-10 aryl, C3-20 cycloalkyl, 3-14 membered heterocyclyl, 5-10 membered heteroaryl, —CRa(═NORb), —S(O)Ra, —S(O)2Ra, —S(O)2NRaRb, —(CH2)nS(O)Ra, —(CH2)nS(O)2Ra, —P(O)RaRb, —CORa, —CSRa, —COORa, —CSORa, —COSRa, —CSSRa, —CONRaRb or —CSNRaRb; wherein the said C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C6-10 aryl, C3-20 cycloalkyl, 3-14 membered heterocyclyl and 5-10 membered heteroaryl, may be substituted with substituents selected from C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C6-10 aryl, C3-20 cycloalkyl, 3-14 membered heterocyclyl, 5-10 membered heteroaryl, —CN, —NO2, NH2; further wherein the said C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C6-10 aryl, C3-20 cycloalkyl, 3-14 membered heterocyclyl and 5-10 membered heteroaryl, may be substituted with substituents selected from R13; R11 represents C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C6-10 aryl, C3-20 cycloalkyl, 3-14 membered heterocyclyl, 5-10 membered heteroaryl, —CN, —COCN, —N3, —NO2, —OCN, —NCO, —SCN, —NCS, —OCONH2, —ONO2, —F, —Cl, —Br, —I, —CO—, —CS—, —CHO, —CHS, —COOH, —COSH, —CONH2, —CONHNH2, —CSNHNH2, —CSNH2, —NH2, —NHCONH2, —NHCSNH2, —NH(C═NH)NH2, —NHNH2, —NHCHO, —NHCHS, —NHCOOH, —NHCSOH, —OH, —SH, —SO3H, —CH(═NOH), —CH(═NCN), —CORa, —CSRa, —COORa, —CSORa, —COSRa, —CONRaRb, —CSNRaRb, —COCORa, —CONRaNRbRc, —CSNRaNRbRc, —CSNRaRb, —NRaRb, —NRaSO2Rb, —NRaCONRbRc, —NRaCSNRbRc, —NRa(C═NRb)NRcRd, —NRaNRbRc, —NRaCORb, —NRaCSRb, —NRaCOORb, —NRaCSORb, —ORa, —OCORa, —OCOORa, —OCONRaRb, —OCSRa, —OCSORa, —ONO2, —OCSNRaRb, —SRa, —S(O)Ra, —S(O)2Ra, —SO2NRaRb, —CRa(═NORb), —CRa (═NCOORb), —CRa(═NSORb), —CRa(═NSO2Rb), —C(═NRa)—NRbRc, —C(═NORa)—NRbRc, —CRa(═NCN), —NCRa, —P(O)RaRb, —P(O)ORaORb, —P(O)RaORb, —P(O)NRaORb, —P(O)NRaRb, —OP(O)RaRb or —NHP(O)RaRb; wherein the said C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C6-10 aryl, C3-20 cycloalkyl, 3-14 membered heterocyclyl and 5-10 membered heteroaryl, may be substituted with substituents selected from R13; R12 represents C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C6-10 aryl, C3-20 cycloalkyl, 3-14 membered heterocyclyl, 5-10 membered heteroaryl, —CN, —COCN, —N3, —NO2, —OCN, —NCO, —SCN, —NCS, —OCONH2, —ONO2, —F, —Cl, —Br, —I, —CO—, —CS—, —CHO, —CHS, —COOH, —COSH, —CONH2, —CONHNH2, —CSNHNH2, —CSNH2, —NH2, —NHCONH2, —NHCSNH2, —NH(C═NH)NH2, —NHNH2, —NHCHO, —NHCHS, —NHCOOH, —NHCSOH, —OH, —SH, —SO3H, —CH(═NOH) or —CH(═NCN); wherein the said C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C6-10 aryl, C3-20 cycloalkyl, 3-14 membered heterocyclyl and 5-10 membered heteroaryl, may be substituted with substituents selected from R13; R13 represents C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C6-10 aryl, C3-20 cycloalkyl, 3-14 membered heterocyclyl, 5-10 membered heteroaryl, —CN, —COCN, —N3, —NO2, —OCN, —NCO, —SCN, —NCS, —OCONH2, —ONO2, —F, —Cl, —Br, —I, —CO—, —CS—, —CHO, —CHS, —COOH, —COSH, —CONH2, —CONHNH2, —CSNHNH2, —CSNH2, —NH2, —NHCONH2, —NHCSNH2, —NH(C═NH)NH2, —NHNH2, —NHCHO, —NHCHS, —NHCOOH, —NHCSOH, —OH, —SH, —SO3H, —CH(═NOH) or —CH(═NCN); Ra, Rb, Rc and Rd are independently selected from —H, C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C6-10 aryl, C3-20 cycloalkyl, 3-14 membered heterocyclyl, 5-10 membered heteroaryl, —CN, —COCN, —N3, —NO2, —OCN, —NCO, —SCN, —NCS, —OCONH2, —ONO2, —F, —Cl, —Br, —I, —CO—, —CS—, —CHO, —CHS, —COOH, —COSH, —CONH2, —CONHNH2, —CSNHNH2, —CSNH2, —NH2, —NHCONH2, —NHCSNH2, —NH(C═NH)NH2, —NHNH2, —NHCHO, —NHCHS, —NHCOOH, —NHCSOH, —OH, —SH, —SO3H, —CH(═NOH), —CH(═NCN); each of which may be substituted with substituents selected from R13; or Ra and Rb when attached to the same atom, can be joined together to form a monocyclic or polycyclic ring, in which one or more methylene groups or methyne groups can be replaced with O, S, SO, SO2, NRa, PRa, P(═O)Ra or oxo; the ring thus formed may be substituted with substituents selected from R12; or Rb and Rc when attached to the same atom, can be joined together to form a monocyclic or polycyclic ring, in which one or more methylene groups or methyne groups can be replaced with O, S, SO, SO2, NRa, PRa, P(═O)Ra or oxo; the ring thus formed may be substituted with substituents selected from R12; or Rc and Rd when attached to the same atom, can be joined together to form a monocyclic or polycyclic ring, in which one or more methylene groups or methyne groups can be replaced with O, S, SO, SO2, NRa, PRa, P(═O)Ra or oxo; the ring thus formed may be substituted with substituents selected from R12; n represents 1, 2, 3, 4 or 5; their pharmaceutically acceptable derivatives, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof.
地址 New Delhi IN